Active substances
Diphtheria toxoid + Tetanus toxoid
- SFDA 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Tedalix | 7.5,2 LfU,LfU | Suspension for injection · Intramuscular use | 1 Vial | SAR 80.05 | Biological · Prescription | ARAB COMPANY FOR PHARMACEUTICAL PRODUCTS (ARABIO) | Valid |
| D.T.VAX | 30 , 40 IU | Suspension · Intramuscular use | 1 Pre-filled syringe | SAR 7.50 | Biological · Prescription | SANOFI PASTEUR | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
BURN MANAGEMENT
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.